Familial hypercholesterolaemia in Finland: Common, rare and mild mutations of the LDL receptor and their clinical consequences

Annals of Medicine

Volumn 33, Issue 6, 2001, Pages 410-421

  Vuorio, A F ^a   Aalto Setala K ^a   Koivisto, U M ^a   Turtola, H ^a   Nissen, H ^a   Kovanen, P T ^a   Miettinen, T A ^a   Gylling, H ^a   Oksanen, H ^a   Kontula, K ^a   Ebeling, T ^a   Huttunen, M ^a   Ilvonen, M ^a   Jokinen, V ^a   Jaaskelainen H ^a   Kesaniemi A ^a   Kaariainen T ^a   Lehtimaki T ^a   Moilanen, V ^a   Maki O ^a   Palomaki A ^a   Penttila O ^a   Pyorala K ^a   Paakkonen P ^a   Ryysy, L ^a   Salmi, J ^a   Saltevo, J ^a   Salvolainen, M ^a   Terava V ^a   Vanamo, R ^a   Vasala, M ^a   Viikari, J ^a   more..

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Atherosclerosis; Diagnosis; DNA; Familial hypercholesterolaemia; Genealogy; LDL receptor; Mutation; North Karelia

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ATHEROSCLEROSIS; AUTOSOMAL INHERITANCE; CHOLESTEROL BLOOD LEVEL; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FINLAND; GENE MUTATION; GENOTYPE; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0034820279     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853890108995954     Document Type: Review

References (68)

1. Familial hypercholesterolemia
2. A receptor-mediated pathway for cholesterol homeostasis
3. Regulation of plasma cholesterol by lipoprotein receptors
4. Genotypic and phenotypic variation in familial hypercholesterolemia
5. The Finnish population structure. A genetic and genealogical structure
6. Molecular genetics of the Finnish disease heritage
7. Mutation in gelsolin gene in Finnish hereditary amyloidosis
8. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease
9. Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: Identification of an apparent founder mutation in the Finns
10. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: Implications for estimation of disease prevalence and molecular diagnostics
11. Finnish type of low density lipoprotein receptor mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype
12. Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland
13. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland
14. A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia
15. Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: Identification of two common missense mutations (Gly823→Asp and Leu380→His) and eight rare mutations of the LDL receptor gene
16. A novel deletion/inversion mutation in the low density lipoprotein receptor as a cause of heterozygous familial hypercholesterolemia
17. Familial moderate hypercholesterolemia caused by Asp235→Glu mutation of the LDL receptor gene and co-occurence of a de novo deletion of the LDL receptor gene in the same family
18. Deletion of exon 15 of the LDL receptor gene is associated with a mild form of familial hypercholesterolemia
19. A novel point mutation (Pro to Ser) of the low density lipoprotein receptor gene in a family with moderate hypercholesterolemia
20. Clinically applicable mutation screening in familial hypercholesterolemia
21. LDLR database (second edition): New additions to the database and the sofware, and results on the first molecular analysis
22. Familial hypercholesterolemia in the Finnish North Karelia: A molecular, clinical and genealogical study
23. Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolemia
24. Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations
25. Effect of the Stul polymorphism in the LDL receptor gene (Ala370 to Thr) on lipid levels in healthy individuals
26. FH Afrikaner-3 LDL receptor mutation results in defective LDL receptors and causes a mild form of familial hypercholesterolemia
27. A mutation (T-45C) in the promoter region of the low-density-lipoprotein (LDL)-receptor gene is associated with a mild clinical phenotype in a patient with heterozygous familial hypercholesterolemia
28. Deletion in the gene for the low-density lipoprotein receptor in a majority of French Canadian with familial hypercholesterolemia
29. Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners
30. The molecular basis and diagnosis of familial hypercholesterolemia in South African Afrikaners
31. Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined familial hypercholesterolemia
32. Mortality over two centuries in large pedigree with familial hypercholesterolemia: Family tree mortality study
33. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections
34. Prevalence of familial hypercholesterolemia among young North Karelian patients with coronary heart disease: A study based on diagnosis by polymerase chain reaction
35. Post-mortem molecularly defined familial hypercholesterolemia and sudden cardiac death of young men
36. Development of coronary heart disease in familial hypercholesterolemia
37. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia
38. Coronary risk factors and the severity of angiographic coronary artery disease in members of high risk pedigrees
39. Relation of lipoprotein(a) to coronary heart disease and duplex-sonographic findings in heterozygous familial hypercholesterolemia
40. Increased prevalence of coronary ectasia in heterozygous familial hypercholesterolemia
41. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation
42. Heterozygous familial hypercholesterolemia. Relationship between plasma lipids, lipoproteins, clinical manifestation and ischaemic heart disease in men and women
43. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia
44. Serum lipoprotein(a) in patients for familial hypercholesterolemia, their relatives, and unrelated control populations
45. Ischaemic disease on men and women with familial hypercholesterolemia and xanthomatosis
46. Mortality and cholesterol metabolism in familial hypercholesterolemia
47. Polymorphism of apolipoprotein E. Effect of single polymorphic gene locus on plasma levels in man
48. Apolipoprotein E phenotyping with a single gel method: Application to the study of informative matings
49. Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E4 in angiographically verified coronary patients
50. Effects of three genetic loci in a pedigree with multiple lipoprotein phenotypes
51. Hypolow density lipoprotein cholesterol effect in apolipoprotein E2 transgenic mice is caused by impaired lipoprotein lipase-mediated lipolysis or triglycetid-rich lipoproteins
52. European and American recommendations for coronary heart disease prevention
53. Association of seropositivity for Chlamydia pneumoniae and coronary artery disease in heterozygous familial hypercholesterolaemia
54. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering
55. Prevalence and extent of atherosclerosis in adolescents and young adults. Implications for prevention from the pathobiological determinants of atherosclerosis in youth study
56. Fatty streak formation occurs in human fetal aortas and is greatly enchanced by maternal hypercholesterolemia: Intimal accumulation of LDL and its oxidation precede monocyte recruitment into early atherosclerotic lesions
57. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of early lesions in children (FELIC) study
58. Lipoprotein metabolism during normal pregnancy
59. Is normal pregnancy atherogenic?
60. Cholesterol-free diet and the physiologic hyperlipidemia of pregnancy in familial hypercholesterolemia
61. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
62. Risk factors related to carotid intimamedia thickness and plaque in children with familial hypercholesterolemia and controls
63. Myocardial infarction and coronary deaths in the World Health Organization WHO MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
64. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population
65. Stanol ester margarine alone and with simvastatin lowers serum cholesterol in families with familial hypercholesterolemia caused by the FH-North Karelia mutation
66. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia
67. AHA Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels. A statement for healthcare professionals from the Nutrition Committee of the Council of Nutrition, Physical Activity, and Metabolism of the American Heart Association
68. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: A randomized controlled trial